Related Experiment Video
Updated: Sep 17, 2025
Retinal and Choroidal Thickness Changes in Populations with Helicobacter pylori Infection by Swept-Source Optical Coherence Tomography
Published on: November 1, 2024
INVESTIGATE THE CHANGE OF CHOROIDAL THICKNESS IN PATIENTS WITH COMMON SYSTEMIC AUTOIMMUNE DISEASES: A Review
Andrew Fang1,2, Ming-Yen Wang1,3, Yo-Chen Chang4,5,6
1School of Post-Baccalaureate Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Purpose:
To evaluate the potential of choroidal thickness, measured through optical coherence tomography, as a biomarker for systemic inflammation in autoimmune diseases.
Methods:
A literature review of MEDLINE/PubMed databases regarding "Choroidal Thickness" in combination with specific autoimmune diseases: "rheumatoid arthritis," "systemic lupus erythematosus," "Behçet disease," "ankylosing spondylitis" and "type 1 diabetes mellitus." The final search was completed on December 13, 2024.
Results:
Most studies revealed that significant thinning of the choroid was noted in rheumatoid arthritis patients, while increased choroidal thickness is associated with active phases of systemic lupus erythematosus, Behçet disease, ankylosing spondylitis, and type 1 diabetes mellitus, with reductions noted during remission.
Conclusion:
Although choroidal thickness shows potential as a biomarker for systemic inflammation, further research with larger sample sizes and longer follow-up periods is needed to confirm its reliability in autoimmune disease monitoring.
More Related Videos
03:35Determining Gender-Based Differences in Retinal and Choroidal Thickness in Underweight Individuals via Swept-Source Optical Coherence Tomography
Published on: December 1, 2023
10:24Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
Published on: February 12, 2018
Related Concept Videos
01:29Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
01:25Glaucoma: Overview